When long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge, it drastically reduced the rate of rapid repeat pregnancy, according to a study of adolescents in Indiana.
An associated ileocecal endometriosis (ICE) location is a marker of severity in 25% cases of women undergoing complete resection for low rectal endometriosis (LRE), according to a retrospective cohort study in BJOG.
Patients with low Endometriosis Fertility Index (EFI) scores may not have a strong chance of a pregnancy achieved without use of assisted reproductive technology (ART), according to a meta-analysis from BJOG.
A pooled analysis of fall incidence showed that denosumab may reduce the risk of falls, as well as provide established fracture risk reduction, according a study published in the Journal of Bone and Mineral Research.
Women with pregestational diabetes mellitus (DM) who recognize benefits in contraception and preconception care are much more likely to use contraception postpartum, according to a survey in the Journal of Obstetrics, Gynecologic & Neonatal Nursing.
Computer-assisted motivational interviewing may not be effective for convincing released female inmates to use contraception, according to new research from Contraception.
A new study in The Journal of Sexual Medicine confirms last year’s revised labeling of the FDA-approved flibanserin for treating HSDD in premenopausal women.
A regimen of an Elaeagnus angustifolia flower capsule or a sildenafil citrate tablet both significantly reduced the frequency of HSDD, according to a recently published study.
Although both treatments increased lumbar spine bone mineral density (BMD) in a retrospective chart review, denosumab demonstrated a significantly greater effect.
For patients with osteoporosis, drug treatments with bisphosphonates may not reduce overall mortality rates, according to a meta-analysis from JAMA Internal Medicine.